A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays-Reference-Cited by-同舟云学术

A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays

Published:2015-03-24 Issue:8 Volume:62 Page:1395-1402
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Suarez Amaranto¹,Piña Martha¹,Nichols-Vinueza Diana X.²,Lopera John¹,Rengifo Lyda¹,Mesa Mauricio¹,Cardenas Marcela¹,Morrissey Lisa²,Veintemilla Galo³,Vizcaino Martha¹,Del Toro Ligia¹,Vicuna Victor¹,Fernandez Jorge⁴,Neuberg Donna⁵,Stevenson Kristen⁵,Gutierrez Alejandro²⁴

Affiliation:

1. Department of Pediatrics; Instituto Nacional de Cancerologia; Bogota Colombia

2. Division of Hematology/Oncology; Boston Children's Hospital; Harvard Medical School; Boston Massachusetts

3. Department of Surgery; Instituto Nacional de Cancerologia; Bogota Colombia

4. Department of Pediatric Oncology; Dana-Farber Cancer Institute; Harvard Medical School; Boston Massachusetts

5. Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute; Harvard Medical School; Boston Massachusetts

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25510/fullpdf

Reference29 articles.

1. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

2. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: Results from a randomized study-dana-Farber Cancer Institute ALL Consortium Protocol 00-01;Vrooman;J Clin Oncol,2013

3. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children's oncology group;Hunger;J Clin Oncol,2012

4. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000;Moricke;Leukemia,2010

5. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries;Metzger;Lancet,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience in improving treatment outcomes for childhood acute lymphoblastic leukemia: real-world results for a province in China, 2011–2020;Leukemia & Lymphoma;2024-05-20

3. Impact of Delay Prior to Treatment in Ethiopian Children with Acute Lymphoblastic Leukemia;Pediatric Health, Medicine and Therapeutics;2023-05

4. Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B‐acute lymphoblastic leukaemia;British Journal of Haematology;2023-03-27

5. Curing the Curable: Managing Low-Risk Acute Lymphoblastic Leukemia in Resource Limited Countries;Journal of Clinical Medicine;2021-10-15